Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
BTK47E
|
|||
| Binder Name |
Escitalopram oxalate
|
|||
| Synonyms |
Lexapro; Escitalopram (oxalate); (S)-Citalopram Oxalate; Cipralex; (S)-(+)Citalopram oxalate; UNII-5U85DBW7LO; 5U85DBW7LO; Lu 26-054-0; C22H23FN2O5; Esertia; Seroplex; NCGC00095903-01; Lu-26-054-0; DSSTox_CID_26003; DSSTox_RID_81282; DSSTox_GSID_46003; Gaudium; Entact; MFCD06407826; Lexapro (TN); SCHEMBL35123; cc-372; MLS001401408; SPECTRUM1505216; (+)-(S)-Citalopram oxalate; MLD-55; CHEMBL1200322; DTXSID1046003; Escitalopram oxalate (JAN/USP); AOB4715; C20H21FN2O.C2H2O4; Escitalopram oxalate [USAN:USP]; HMS2051D11; HMS2231M16; HMS3370I17; HMS3393D11; HMS3713D16; Pharmakon1600-01505216; BCP05686; Tox21_111535; CCG-39559; HY-14258A; NSC758934; AKOS016340275; Tox21_111535_1; AC-6770; CS-2054; KS-1263; NC00194; NSC-758934; SB17454; LU-26-054-O; NCGC00178555-02; AK138215; SMR000469191; AB0012102; E0958; D02567; Escitalopram oxalate, >=98% (HPLC), powder; J90016; SR-01000763053; SR-01000763053-3; Q27262882; UNII-B5RDX2419X component KTGRHKOEFSJQNS-BDQAORGHSA-N; Escitalopram oxalate, EuropePharmacopoeia (EP) Reference Standard; Escitalopram oxalate, United States Pharmacopeia (USP) Reference Standard
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C22H23FN2O5
|
|||
| Canonical SMILES |
CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O
|
|||
| InChI |
1S/C20H21FN2O.C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;3-1(4)2(5)6/h4-9,12H,3,10-11,14H2,1-2H3;(H,3,4)(H,5,6)/t20-;/m0./s1
|
|||
| InChIKey |
KTGRHKOEFSJQNS-BDQAORGHSA-N
|
|||
| PubChem Compound ID | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.